focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European stocks muted as new lockdown outweighs strong business activity data

Wed, 24th Mar 2021 09:52

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* EU records strong flash PMIs, consumer confidence improves

* EU to extend vaccine export curbs

* Chip stocks jump on Intel's spending plan
(Adds comments, updates prices throughout)

By Sruthi Shankar and Shreyashi Sanyal

March 24 (Reuters) - European stocks were subdued on
Wednesday, as concerns about new lockdown measures overshadowed
a surprise return to economic growth for the euro zone in March.

After falling as much as 0.7% in earlier in the day, the
pan-European STOXX 600 index ended flat.

Euro zone stocks also cut losses after IHS
Markit's flash composite PMI, seen as a good guide to economic
health, bounced above the 50 mark, separating growth from
contraction, to 52.5 this month compared with February's 48.8.

While the data gave investors some relief, a third wave of
coronavirus infections and renewed lockdown measures in Europe,
as well as a slow vaccine roll-out are likely to weigh on the
final reading of the survey and April's numbers.

"We believe this is a pause, not the end of the equity rally
yet," said Michele Morganti, an equity strategist at Generali
Insurance Asset Management.

"COVID management is a bumpy road. We nevertheless think
that recovery will be quite strong in the second half of the
year."

Another piece of data showed a flash estimate of euro zone
consumer morale improved to -10.8 this month from -14.8 in
February.

"The sharp increase in euro zone consumer confidence in
March came as a big surprise given tighter restrictions across
the bloc and ongoing difficulties with the AstraZeneca vaccine,"
said Melanie Debono, Europe economist at Capital Economics.

The European stocks benchmark has pulled away from a
one-year peak hit last week after major economies like Germany
and France imposed new lockdowns.

Meanwhile, the European Union is set to extend COVID-19
vaccine export curbs to Britain and other areas with much higher
vaccination rates, and to cover instances of companies
backloading contracted supplies, EU officials said.

Among individual stocks, Italian defence and aerospace group
Leonardo fell -6.1% after it postponed the initial
public offering of its U.S. electronics unit DRS

Commerzbank rose 1.6% even as Germany's No. 2
lender said it expects a net loss for 2021.

Big gains for chipmakers helped limit market losses.

Shares in ASM International, ASML and
Infineon Technologies, were up between 0.3% and 5.2%
after U.S. firm Intel Corp announced a $20 billion plan
to expand its advanced chip manufacturing capacity.

French supermarket retailer Carrefour rose 2.3%
after saying it had agreed to buy Brazil's third biggest food
retailer Grupo BIG in a deal that values it at $1.3 billion.
(Reporting by Sruthi Shankar and Shreyashi Sanyal in Bengaluru;
Editing by Arun Koyyur)

More News
16 May 2024 10:27

AstraZeneca trials yield positive results for immunocompromised patients

(Alliance News) - AstraZeneca PLC on Thursday said results from recent trials revealed a significant reduction in cases of Covid-19.

Read more
12 May 2024 13:25

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business summit.

Read more
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.